The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.

中文翻译：

---

三尖瓣疾病与心脏植入电子设备

心脏植入电子设备（CIED）相关的三尖瓣反流（TR）的作用越来越被认为是一个独立的临床实体。因此，介入 TR 治疗方案不断发展，手术风险评估和围手术期护理改善了 CIED 相关 TR 的管理，并且引线拔除的作用引起了高度关注。此外，新型手术和介入三尖瓣治疗方案越来越多地应用于患有与 CIED 相关或相关的 TR 的患者。这篇由电生理学家、介入心脏病学家、影像学专家和心脏外科医生共同撰写的多学科综述文章旨在概述疾病机制、诊断，并提出与 CIED 导线或无导线起搏器相关的 TR 患者的治疗方案。